Biblio Discovery — Demo Discovery Service

23 hasil untuk "Po-Lin Tseng"

Menampilkan 1–20 · 0,72 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice

    Ming-Tsung Lin; Yi-Hao Yen; Ming-Chao Tsai dkk.

    PLOS ONE, Vol. 11 No. 11 · 2016 · Inggris · PLOS Scopus

    Background and Aim: Chronic hepatitis B infection remains a significant health issue worldwide. This study evaluated the efficacy and safety of combined therapy using lamivudine plus adefovir (LAM+ADV) versus telbivudine plus adefovir (LdT+ADV) and the corresponding renal function change and…

    Juga tersedia di: DOAJ

  2. Artikel Jurnal

    Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy

    Kuo-Chin Chang; Yi-Hao Ye; Cheng-Kun Wu dkk.

    Journal of the Formosan Medical Association, Vol. 117 No. 11 · 2018 · Inggris · DOAJ Scopus

    Background/Purpose: Although antiviral therapy reduces development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC), HCC often develops in patients with non-sustained virologic response (non-SVR). We aimed to evaluate risk factors for HCC in HCV patients with non-SVR…

  3. Artikel Jurnal

    Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy

    Hsin-Wei Fang; Po-Lin Tseng; Tsung-Hui Hu dkk.

    Virology Journal, Vol. 21 No. 1 · 2024 · Inggris · DOAJ Scopus

    Abstract Background No study has comparing hepatitis B virus (HBV) relapse rates among patients with both cancer and hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) who completed anti-viral prophylaxis for chemotherapy and then stopped taking entecavir or tenofovir alafenamide…

  4. Artikel Jurnal Teks lengkap

    Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study

    Ming-Chao Tsai; Chien-Hung Chen; Po-Lin Tseng dkk.

    PLOS ONE, Vol. 11 No. 3 · 2016 · Inggris · PLOS Scopus

    This study aimed to assess the renal function in chronic hepatitis B (CHB) patients who received nucleos(t)ide analogues (NAs) therapy using estimated glomerular filtration rate (eGFR) titer. We performed a longitudinal observational study of 37 tenofovir-, 42 telbivudine-, and 62 entecavir-naïve…

    Juga tersedia di: DOAJ

  5. Artikel Jurnal

    Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation

    Shih-Yu Yang; Tsung-Hui Hu; Yeh-Pin Chou dkk.

    Journal of Infection and Public Health, Vol. 16 No. 11 · 2023 · Inggris · DOAJ Scopus

    Background: Prophylaxis antiviral therapy is recommended for patients with hepatitis B receiving chemotherapy but the ideal treatment duration after chemotherapy cessation needs more evidence for clarification. Aims: This study aimed to compare the relapse rate of short finite intervals of 6 months…

  6. Artikel Jurnal

    A Real World Report on Intravenous High-Dose and Non-High-Dose Proton-Pump Inhibitors Therapy in Patients with Endoscopically Treated High-Risk Peptic Ulcer Bleeding

    Lung-Sheng Lu; Sheng-Chieh Lin; Chung-Mou Kuo dkk.

    Gastroenterology Research and Practice, Vol. 2012 · 2012 · Inggris · DOAJ Scopus

    Background and Study Aims. The optimal dose of intravenous proton-pump inhibitor (PPI) therapy for the prevention of peptic ulcer (PU) rebleeding remains controversial. This study aimed to understand the real world experiences in prescribing high-dose PPI and non-high-dose PPI for preventing…

  7. Artikel Jurnal Teks lengkap

    Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study

    Yi-Hao Yen; Jin-Bor Chen; Ben-Chung Cheng dkk.

    PLOS ONE, Vol. 12 No. 4 · 2017 · Inggris · PLOS Scopus

    Background and aims: Controlled attenuation parameter (CAP) is a non-invasive method for measuring hepatic steatosis (HS). Non-alcoholic fatty liver disease (NAFLD) is closely related to cardiovascular diseases (CVDs). CVDs are the leading cause of morbidity and mortality in hemodialysis patients…

    Juga tersedia di: DOAJ

  8. Artikel Jurnal Teks lengkap

    The Changes of Liver Stiffness and Its Associated Factors for Chronic Hepatitis B Patients with Entecavir Therapy

    Yuan-Hung Kuo; Sheng-Nan Lu; Chien-Hung Chen dkk.

    PLoS ONE, Vol. 9 No. 3 · 2014 · Inggris · PLOS Scopus

    Liver stiffness measurement (LSM) using transient elastography has been proposed to assess liver fibrosis well in various liver diseases. This study was to determine the changes of LSM and its associated factors for chronic hepatitis B (CHB) patients undergoing Entecavir therapy. Consecutive CHB…

    Juga tersedia di: DOAJ

  9. Artikel Jurnal Teks lengkap

    Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis

    Ming-Tsung Lin; Chih-Chi Wang; Yu-Fan Cheng dkk.

    PLOS ONE, Vol. 11 No. 11 · 2016 · Inggris · PLOS Scopus

    Background & Aims: Liver computed tomography and dynamic magnetic resonance imaging play an important role in the early detection of hepatocellular carcinoma. However, the American Association for the Study of Liver Diseases (AASLD) recommend the use of applied imaging studies for HCC diagnosis…

    Juga tersedia di: DOAJ

  10. Artikel Jurnal

    The correlation of controlled attenuation parameter results with ultrasound-identified steatosis in real-world clinical practice

    Yi-Hao Yen; Jung-Fu Chen; Cheng-Kun Wu dkk.

    Journal of the Formosan Medical Association, Vol. 116 No. 11 · 2017 · Inggris · DOAJ Scopus

    Controlled attenuation parameter (CAP) is a method for measuring steatosis based on FibroScan. Despite observer dependency, ultrasound (US) robustly diagnoses moderate and severe steatosis. Here, we aimed to evaluate the correlation of CAP with US-identified steatosis in real-world clinical…

  11. Artikel Jurnal Teks lengkap

    Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels

    Cheng-Kung Wu; Kuo-Chin Chang; Po-Lin Tseng dkk.

    PLOS ONE, Vol. 11 No. 3 · 2016 · Inggris · PLOS Scopus

    Background and Aims: Patients with chronic hepatitic C (HCV) infection and normal serum alanine transaminase (ALT) levels were considered to have mild disease. In Taiwan, these patients were not suggested for interferon (IFN) based therapies. The aim of study is to compare therapeutic outcomes…

    Juga tersedia di: DOAJ

  12. Artikel Jurnal

    Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease

    Yi-Hao Yen; Kuo-Chin Chang; Ming-Chao Tsai dkk.

    Journal of the Formosan Medical Association, Vol. 117 No. 4 · 2018 · Inggris · DOAJ Scopus

    Background/Purpose: Metabolic risk factors are associated with liver fibrosis. Whether or not metabolic risk factors affect the severity of liver fibrosis in patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), or risk factors associated with non-alcoholic fatty liver disease (NAFLD)…

  13. Artikel Jurnal

    Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations

    Po-Lin Tseng; Jing-Houng Wang; Chao-Hung Hung dkk.

    Kaohsiung Journal of Medical Sciences, Vol. 29 No. 7 · 2013 · Inggris · DOAJ Scopus

    Several noninvasive indices have been proposed for predicting liver cirrhosis (LC), particularly in chronic hepatitis C (CHC). In this study, noninvasive indices for predicting LC and hepatocellular carcinoma (HCC) were compared. A total of 119 chronic hepatitis B (CHB) patients and 240 CHC…

  14. Artikel Jurnal

    Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan

    Chao-Tung Chen; Jing-Yi Chen; Jing-Houng Wang dkk.

    Kaohsiung Journal of Medical Sciences, Vol. 29 No. 8 · 2013 · Inggris · DOAJ Scopus

    A prominent factor in hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). Diabetes mellitus (DM), metabolic syndrome (MetS), and obesity have also been implicated in HCC development, but these associations are not observed in all HBV- and…